Wong-Ho Chow
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Wong-Ho Chow has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Nathaniel Rothman
National Cancer Institute 1 Division of Cancer Epidemiology and Genetics Bethesda, Maryland
5 shared publications - Bu-Tian Ji
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
4 shared publications Wei Zheng
Vandverbilt University Medical Centre, Nashville, USA
4 shared publicationsSusan S. Devesa
Division of Cancer Epidemiology and Genetics, US Department of Health and Human Services, National Cancer Institute, National Institutes of Health, 6120 Executive Boulevard, EPS 8100, Bethesda, 20892-7240, MD, USA
3 shared publications- Yu-Tang Gao
Shanghai Cancer Institute, Shanghai, China
3 shared publications Gloria Gridley
2 shared publications
Latest Publications
- 1 September 2016
- Published by BMJ
- Vol. 73, A90-A91
O47-6 Impact of calibrating a benzene job-exposure matrix with measurements on exposure-response associations for non-hodgkin lymphoma
Objectives To provide insight into the contributions of exposure measurements to job exposure matrices (JEMs), we examined the sensitivity of exposure-response associations between occupational benzene exposure and non-Hodgkin lymphoma (NHL) using benzene JEM-based estimates with and without measurement calibration. Methods NHL risk was examined in a prospective population-based cohort of 73,087 Shanghai women with no prevalent cancer at baseline and a valid occupational history. An ‘uncalibrated’ benzene JEM was developed using expert judgment to assign ordinal (0 to 3) probability and intensity ratings to each occupation and industry group. JEM intensity estimates were combined with >60,000 short-term, area benzene inspection measurements using a mixed-effects model framework that incorporated fixed effects for year and intensity rating and random effects for occupation, industry, and measurement occurrence. The model was used to derive ‘calibrated JEM’ estimates from the fixed effect model parameters and ‘job/industry-specific’ estimates from both the fixed effect model parameters and the best unbiased linear prediction estimates from the occupation and industry random effect terms. Cumulative exposure for each subject was calculated for each approach using varying exposure definition criteria based on the JEM’s probability ratings. We examined the agreement between the cumulative metrics and evaluated changes in the benzene-NHL associations. Results For our primary exposure definition, the job/industry-specific estimates were moderately to highly correlated with the calibrated and uncalibrated JEM estimates (Spearman correlation amongst exposed subjects: 0.64–0.87). The uncalibrated, calibrated, and job/industry-specific metrics all resulted in statistically significant exposure-response associations for NHL, with similar model fit. This similarity occurred because the measurement- and ordinal-based weights across the occupation intensity ratings were nearly identical in this study. Conclusions The measurement-based JEM estimates had similar model fit to the uncalibrated JEM estimates in this study; however, the measurement-based estimates allowed us to evaluate quantitative exposure-response curves.
- 1 September 2016
- Published by BMJ
- Vol. 73, A90-A91
O47-6 Impact of calibrating a benzene job-exposure matrix with measurements on exposure-response associations for non-hodgkin lymphoma
Objectives To provide insight into the contributions of exposure measurements to job exposure matrices (JEMs), we examined the sensitivity of exposure-response associations between occupational benzene exposure and non-Hodgkin lymphoma (NHL) using benzene JEM-based estimates with and without measurement calibration. Methods NHL risk was examined in a prospective population-based cohort of 73,087 Shanghai women with no prevalent cancer at baseline and a valid occupational history. An ‘uncalibrated’ benzene JEM was developed using expert judgment to assign ordinal (0 to 3) probability and intensity ratings to each occupation and industry group. JEM intensity estimates were combined with >60,000 short-term, area benzene inspection measurements using a mixed-effects model framework that incorporated fixed effects for year and intensity rating and random effects for occupation, industry, and measurement occurrence. The model was used to derive ‘calibrated JEM’ estimates from the fixed effect model parameters and ‘job/industry-specific’ estimates from both the fixed effect model parameters and the best unbiased linear prediction estimates from the occupation and industry random effect terms. Cumulative exposure for each subject was calculated for each approach using varying exposure definition criteria based on the JEM’s probability ratings. We examined the agreement between the cumulative metrics and evaluated changes in the benzene-NHL associations. Results For our primary exposure definition, the job/industry-specific estimates were moderately to highly correlated with the calibrated and uncalibrated JEM estimates (Spearman correlation amongst exposed subjects: 0.64–0.87). The uncalibrated, calibrated, and job/industry-specific metrics all resulted in statistically significant exposure-response associations for NHL, with similar model fit. This similarity occurred because the measurement- and ordinal-based weights across the occupation intensity ratings were nearly identical in this study. Conclusions The measurement-based JEM estimates had similar model fit to the uncalibrated JEM estimates in this study; however, the measurement-based estimates allowed us to evaluate quantitative exposure-response curves.
- Open Access
- 3 March 2013
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 22 (10) , 2128
Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer
Human Molecular Genetics 2012; 22:4; pp. 825–831; doi:10.1093/hmg/dds489
- 3 March 2013
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 22 (10) , 2128
Open AccessCommon variation at 2q22.3 (ZEB2) influences the risk of renal cancer
Human Molecular Genetics 2012; 22:4; pp. 825–831; doi:10.1093/hmg/dds489
- 1 September 2012
- Published by Wolters Kluwer Health in Epidemiology
- Vol. 23
P-225
- Top Cited Papers
- 1 May 2010
- Published by Springer Nature in Nature Reviews Urology
- Vol. 7 (5) , 245-257
Epidemiology and risk factors for kidney cancer
Overall kidney cancer incidence shows signs of stabilizing, or even decreasing worldwide, except in the US, where renal cell carcinoma incidence continues to rise. This Review by Chow and colleagues discusses the descriptive incidence and changing prevalence of risk factor patterns of adult kidney carcinoma, both internationally and in the US. After more than two decades of rising rates, in recent years the total kidney cancer incidence worldwide has shown signs of stabilizing, or even decreasing. In adults, kidney cancer consists of renal cell carcinoma (RCC), the predominant form, and renal transitional cell carcinoma (RTCC); these types primarily arise in the renal parenchyma and renal pelvis, respectively. Although temporal trends by kidney cancer type are not well established worldwide, incidence of RCC in the US has continued to rise, mainly for early-stage tumors, while that of RTCC has declined, and total kidney cancer mortality rates have leveled. Stabilization of kidney cancer mortality rates has also been reported in Europe. These trends are consistent with reports of increasing incidental diagnoses and a downward shift in tumor stage and size in clinical series. The changing prevalence of known risk factors for RCC, including cigarette smoking, obesity, and hypertension, is also likely to affect incidence trends, although their relative impact may differ between populations. Accumulating evidence suggests an etiologic role in RCC for physical activity, alcohol consumption, occupational exposure to trichloroethylene, and high parity among women, but further research is needed into the potential causal effects of these factors. Genetic factors and their interaction with environmental exposures are believed to influence risk of developing RCC, but a limited number of studies using candidate-gene approaches have not produced conclusive results. Large consortium efforts employing genome-wide scanning technology are underway, which hold promise for novel discoveries in renal carcinogenesis.
- 1 May 2010
- Published by Springer Nature in Nature Reviews Urology
- Vol. 7 (5) , 245-257
Top Cited PapersEpidemiology and risk factors for kidney cancer
Overall kidney cancer incidence shows signs of stabilizing, or even decreasing worldwide, except in the US, where renal cell carcinoma incidence continues to rise. This Review by Chow and colleagues discusses the descriptive incidence and changing prevalence of risk factor patterns of adult kidney carcinoma, both internationally and in the US. After more than two decades of rising rates, in recent years the total kidney cancer incidence worldwide has shown signs of stabilizing, or even decreasing. In adults, kidney cancer consists of renal cell carcinoma (RCC), the predominant form, and renal transitional cell carcinoma (RTCC); these types primarily arise in the renal parenchyma and renal pelvis, respectively. Although temporal trends by kidney cancer type are not well established worldwide, incidence of RCC in the US has continued to rise, mainly for early-stage tumors, while that of RTCC has declined, and total kidney cancer mortality rates have leveled. Stabilization of kidney cancer mortality rates has also been reported in Europe. These trends are consistent with reports of increasing incidental diagnoses and a downward shift in tumor stage and size in clinical series. The changing prevalence of known risk factors for RCC, including cigarette smoking, obesity, and hypertension, is also likely to affect incidence trends, although their relative impact may differ between populations. Accumulating evidence suggests an etiologic role in RCC for physical activity, alcohol consumption, occupational exposure to trichloroethylene, and high parity among women, but further research is needed into the potential causal effects of these factors. Genetic factors and their interaction with environmental exposures are believed to influence risk of developing RCC, but a limited number of studies using candidate-gene approaches have not produced conclusive results. Large consortium efforts employing genome-wide scanning technology are underway, which hold promise for novel discoveries in renal carcinogenesis.
- Open Access
- 7 April 2010
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 171 (9) , 953-959
Night-Shift Work and Breast Cancer Risk in a Cohort of Chinese Women
Shift work involving disruption of circadian rhythms has been classified as a probable cause of human cancer by the International Agency for Research on Cancer, based on limited epidemiologic evidence and abundant experimental evidence. The authors investigated this association in a population-based prospective cohort study of Chinese women. At baseline (1996–2000), information on lifetime occupational history was obtained from 73,049 women. Lifetime night-shift exposure indices were created using a job exposure matrix. During 2002–2004, self-reported data on frequency and duration of night-shift work were collected. Hazard ratios and 95% confidence intervals, adjusted for major breast cancer risk factors, were calculated. During follow-up through 2007, 717 incident cases of breast cancer were diagnosed. Breast cancer risk was not associated with ever working the night shift on the basis of the job exposure matrix (adjusted hazard ratio = 1.0, 95% confidence interval: 0.9, 1.2) or self-reported history of night-shift work (adjusted hazard ratio = 0.9, 95% confidence interval: 0.7, 1.1). Risk was also not associated with frequency, duration, or cumulative amount of night-shift work. There were no indications of effect modification. The lack of an association between night-shift work and breast cancer adds to the inconsistent epidemiologic evidence. It may be premature to consider shift work a cause of cancer.
- 7 April 2010
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 171 (9) , 953-959
Open AccessNight-Shift Work and Breast Cancer Risk in a Cohort of Chinese Women
Shift work involving disruption of circadian rhythms has been classified as a probable cause of human cancer by the International Agency for Research on Cancer, based on limited epidemiologic evidence and abundant experimental evidence. The authors investigated this association in a population-based prospective cohort study of Chinese women. At baseline (1996–2000), information on lifetime occupational history was obtained from 73,049 women. Lifetime night-shift exposure indices were created using a job exposure matrix. During 2002–2004, self-reported data on frequency and duration of night-shift work were collected. Hazard ratios and 95% confidence intervals, adjusted for major breast cancer risk factors, were calculated. During follow-up through 2007, 717 incident cases of breast cancer were diagnosed. Breast cancer risk was not associated with ever working the night shift on the basis of the job exposure matrix (adjusted hazard ratio = 1.0, 95% confidence interval: 0.9, 1.2) or self-reported history of night-shift work (adjusted hazard ratio = 0.9, 95% confidence interval: 0.7, 1.1). Risk was also not associated with frequency, duration, or cumulative amount of night-shift work. There were no indications of effect modification. The lack of an association between night-shift work and breast cancer adds to the inconsistent epidemiologic evidence. It may be premature to consider shift work a cause of cancer.
- Top Cited Papers
- 1 March 2009
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 38 (1) , 27-57
Environmental Causes of Esophageal Cancer
- 1 March 2009
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 38 (1) , 27-57
Top Cited PapersEnvironmental Causes of Esophageal Cancer
- 1 September 2008
- Published by Wolters Kluwer Health in The Cancer Journal
- Vol. 14 (5) , 288-301
Contemporary Epidemiology of Renal Cell Cancer
We analyzed renal cell cancer incidence patterns in the United States and reviewed recent epidemiologic evidence with regard to environmental and host genetic determinants of renal cell cancer risk. Renal cell cancer incidence rates continued to rise among all racial/ethnic groups in the United States, across all age groups, and for all tumor sizes, with the most rapid increases for localized stage disease and small tumors. Recent cohort studies confirmed the association of smoking, excess body weight, and hypertension with an elevated risk of renal cell cancer, and suggested that these factors can be modified to reduce the risk. There is increasing evidence for an inverse association between renal cell cancer risk and physical activity and moderate intake of alcohol. Occupational exposure to trichloroethylene has been positively associated with renal cell cancer risk in several recent studies, but its link with somatic mutations of the von Hippel-Lindau gene has not been confirmed. Studies of genetic polymorphisms in relation to renal cell cancer risk have produced mixed results, but genome-wide association studies with larger sample size and a more comprehensive approach are underway. Few epidemiologic studies have evaluated risk factors by subtypes of renal cell cancer defined by somatic mutations and other tumor markers.
- 1 September 2008
- Published by Wolters Kluwer Health in The Cancer Journal
- Vol. 14 (5) , 288-301
Contemporary Epidemiology of Renal Cell Cancer
We analyzed renal cell cancer incidence patterns in the United States and reviewed recent epidemiologic evidence with regard to environmental and host genetic determinants of renal cell cancer risk. Renal cell cancer incidence rates continued to rise among all racial/ethnic groups in the United States, across all age groups, and for all tumor sizes, with the most rapid increases for localized stage disease and small tumors. Recent cohort studies confirmed the association of smoking, excess body weight, and hypertension with an elevated risk of renal cell cancer, and suggested that these factors can be modified to reduce the risk. There is increasing evidence for an inverse association between renal cell cancer risk and physical activity and moderate intake of alcohol. Occupational exposure to trichloroethylene has been positively associated with renal cell cancer risk in several recent studies, but its link with somatic mutations of the von Hippel-Lindau gene has not been confirmed. Studies of genetic polymorphisms in relation to renal cell cancer risk have produced mixed results, but genome-wide association studies with larger sample size and a more comprehensive approach are underway. Few epidemiologic studies have evaluated risk factors by subtypes of renal cell cancer defined by somatic mutations and other tumor markers.
- 25 January 2008
- Vol. 27, 4243-7
COX1 and COX2 polymorphisms and gastric cancer risk in a Polish population.
Although a number of studies on the polymorphisms in COX1 and COX2 genes in association with risks for a number of cancers have been conducted, their relation to gastric cancer has not been well studied. Genotypes of several variants in both COX1 (Ex7+31 C>A and Ex10-4 G>A) and COX2 (-765 G>C, Ex10+837 T>C, Ex10-90 C>T, IVS5-275 T>G, and IVS7+111 T>C) were identified by TaqMan assays in 305 gastric cancer cases and 427 age- and gender-matched controls in a high-risk Polish population. Odds ratios for gastric cancer and 95% confidence intervals from unconditional logistic regression models were used to evaluate relative risks. We found no statistically significant evidence that the polymorphisms tested in COX1 and COX2 are associated with gastric cancer risk. These results suggest that the polymorphisms examined in COX1 and COX2 do not affect the risk of gastric cancer.
- 25 January 2008
- Vol. 27, 4243-7
COX1 and COX2 polymorphisms and gastric cancer risk in a Polish population.
Although a number of studies on the polymorphisms in COX1 and COX2 genes in association with risks for a number of cancers have been conducted, their relation to gastric cancer has not been well studied. Genotypes of several variants in both COX1 (Ex7+31 C>A and Ex10-4 G>A) and COX2 (-765 G>C, Ex10+837 T>C, Ex10-90 C>T, IVS5-275 T>G, and IVS7+111 T>C) were identified by TaqMan assays in 305 gastric cancer cases and 427 age- and gender-matched controls in a high-risk Polish population. Odds ratios for gastric cancer and 95% confidence intervals from unconditional logistic regression models were used to evaluate relative risks. We found no statistically significant evidence that the polymorphisms tested in COX1 and COX2 are associated with gastric cancer risk. These results suggest that the polymorphisms examined in COX1 and COX2 do not affect the risk of gastric cancer.
- Open Access
- 3 April 2007
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 99 (7) , 569-570
Re: Rising Incidence of Small Renal Masses: A Need to Reassess Treatment Effect
The trends in mortality rates according to tumor size for renal cell cancer (RCC) patients that were calculated by Hollingsworth et al. ( 1 ) are misleading because most RCC patients survive beyond the year that they are diagnosed. The prolonged survival means that the mortality rates for patients diagnosed during a confined period (1983–2002) should be low during the initial years and increase over time as more patients diagnosed during the early years die. In Table 1 , we present two sets of total mortality rates based on data from the Surveillance, Epidemiology, and End Results (SEER) incidence-based mortality file ( 2 )—one set for cases diagnosed during 1983–2002 (henceforth referred to as the restricted period) and the other for all cases diagnosed since the beginning of the SEER program (1973–2002, henceforth referred to as the whole period). Using the restricted dataset, the total mortality rates increased from 1.6/100000 in 1983 to 6.5/100000 in 2002, an increase of nearly 300% that is comparable to that reported by the authors. In contrast, based on the whole dataset, the increases in total mortality rates during 1983–2002 were much smaller, from 4.6/100000 in 1983 to 6.8/100000 in 2002, a 48% increase. The discrepancy in the increase in mortality rates was mostly due to higher mortality rates during the 1980s in the whole dataset relative to rates in the restricted dataset; the mortality rates in later years were more comparable. It is noteworthy that the mortality rates for patients with tumors of unknown size in the whole dataset declined steadily during the same time period, while rates in the restricted dataset stayed relatively constant. The difference in the trends was due mainly to omission of case subjects diagnosed before 1983, for whom information on tumor size was not available, and the declining contributions of these subjects to subsequent deaths over time. Similar discrepancies in mortality rates between the whole and restricted datasets emerged when only deaths due to kidney cancer were included ( Table 1 ).
- 3 April 2007
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 99 (7) , 569-570
Open AccessRe: Rising Incidence of Small Renal Masses: A Need to Reassess Treatment Effect
The trends in mortality rates according to tumor size for renal cell cancer (RCC) patients that were calculated by Hollingsworth et al. ( 1 ) are misleading because most RCC patients survive beyond the year that they are diagnosed. The prolonged survival means that the mortality rates for patients diagnosed during a confined period (1983–2002) should be low during the initial years and increase over time as more patients diagnosed during the early years die. In Table 1 , we present two sets of total mortality rates based on data from the Surveillance, Epidemiology, and End Results (SEER) incidence-based mortality file ( 2 )—one set for cases diagnosed during 1983–2002 (henceforth referred to as the restricted period) and the other for all cases diagnosed since the beginning of the SEER program (1973–2002, henceforth referred to as the whole period). Using the restricted dataset, the total mortality rates increased from 1.6/100000 in 1983 to 6.5/100000 in 2002, an increase of nearly 300% that is comparable to that reported by the authors. In contrast, based on the whole dataset, the increases in total mortality rates during 1983–2002 were much smaller, from 4.6/100000 in 1983 to 6.8/100000 in 2002, a 48% increase. The discrepancy in the increase in mortality rates was mostly due to higher mortality rates during the 1980s in the whole dataset relative to rates in the restricted dataset; the mortality rates in later years were more comparable. It is noteworthy that the mortality rates for patients with tumors of unknown size in the whole dataset declined steadily during the same time period, while rates in the restricted dataset stayed relatively constant. The difference in the trends was due mainly to omission of case subjects diagnosed before 1983, for whom information on tumor size was not available, and the declining contributions of these subjects to subsequent deaths over time. Similar discrepancies in mortality rates between the whole and restricted datasets emerged when only deaths due to kidney cancer were included ( Table 1 ).
- 1 April 2003
- Vol. 12 (4) , 384-6
No apparent association between NAT1 and NAT2 genotypes and risk of stomach cancer.
- 1 April 2003
- Vol. 12 (4) , 384-6
No apparent association between NAT1 and NAT2 genotypes and risk of stomach cancer.